Beta Bionics, Inc. (BBNX) Research & Development (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Research & Development data on file, last reported at $10.4 million in Q1 2026.

• Quarterly Research & Development rose 36.44% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.6 million (up 32.73% YoY) and the FY2025 annual result came in at $34.8 million, up 32.86% from the prior year.
• Research & Development advanced to $10.4 million in Q1 2026 per BBNX's latest filing, from $10.1 million in the prior quarter.
• The five-year high for Research & Development was $10.4 million in Q1 2026, with the low at $5.1 million in Q3 2024.
• Average Research & Development over 3 years is $7.9 million, with a median of $8.2 million recorded in 2025.
• The widest YoY moves for Research & Development: up 59.4% in 2025, down 9.95% in 2025.
• Beta Bionics' Research & Development stood at $9.2 million in 2024, then advanced by 9.95% to $10.1 million in 2025, then advanced by 2.22% to $10.4 million in 2026.
• Business Quant data shows BBNX's Research & Development at $10.4 million in Q1 2026, $10.1 million in Q4 2025, and $8.2 million in Q3 2025.